RAC 1.11% $1.83 race oncology ltd

Cardioprotection thread, page-436

  1. 2,621 Posts.
    lightbulb Created with Sketch. 2756
    Agree we need P2 to maximise any deal and timeline is years off so patience is required. That’s what the Cosela (example) and Race trial timeframes / triangle report suggest.

    P1 results will give insight into proof of concept for CPACS and thus a ‘major’ turning point in the development of RC220.

    If you think P1 is ONLY a safety trial then think again. If CPACS isn’t present in P1 then I’m doubtful P2/P3
    would show otherwise.

    This is due to the way Cardio protection and FTO inhibition work.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.